Action plan for drug-resistant Streptococcus pneumoniae. The DRSP Working Group.
M S
MS
Cetron
D B
DB
Jernigan
R F
RF
Breiman
D000900:Anti-Bacterial Agents / Q000009:adverse effects / Q000627:therapeutic use*; D016470:Bacteremia / Q000188:drug therapy / Q000453:epidemiology; D002487:Centers for Disease Control and Prevention, U.S. / Q000458:organization & administration; D004352:Drug Resistance, Microbial; D006801:Humans; D016920:Meningitis, Bacterial / Q000188:drug therapy / Q000453:epidemiology; D011008:Pneumococcal Infections / Q000188:drug therapy* / Q000453:epidemiology / Q000517:prevention & control / Q000635:transmission; D011018:Pneumonia, Pneumococcal / Q000188:drug therapy / Q000453:epidemiology; D011159:Population Surveillance; D013296:Streptococcus pneumoniae / Q000187:drug effects / Q000276:immunology / Q000472:pathogenicity; D014481:United States; D014611:Vaccination
D000900:Anti-Bacterial Agents